Cognition Therapeutics (CGTX)
(Delayed Data from NSDQ)
$1.95 USD
+0.02 (1.04%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $1.95 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/2/24 |
---|---|
Current Quarter | -0.23 |
EPS Last Quarter | -0.27 |
Last EPS Surprise | 28.95% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.98 |
Next Year | -1.38 |
EPS (TTM) | -0.86 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.23 | -0.15 | -0.98 | -1.38 |
# of Estimates | 1 | 1 | 4 | 2 |
Most Recent Consensus | -0.23 | -0.15 | -0.62 | NA |
High Estimate | -0.23 | -0.15 | -0.62 | -0.93 |
Low Estimate | -0.23 | -0.15 | -1.34 | -1.83 |
Year ago EPS | -0.21 | -0.16 | -0.86 | -0.98 |
Year over Year Growth Est. | -9.52% | 6.25% | -13.95% | -40.82% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 1 | 0 |
Up Last 60 Days | 0 | 0 | 2 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 1 | 0 |
Down Last 60 Days | 0 | 0 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.23 | -0.15 | -0.98 | -1.38 |
7 Days Ago | -0.23 | -0.15 | -0.98 | -1.38 |
30 Days Ago | NA | NA | -1.01 | -1.83 |
60 Days Ago | NA | NA | -1.10 | -2.25 |
90 Days Ago | NA | NA | -1.10 | -2.25 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.23 | -0.15 | -0.94 | -1.38 |
Zacks Consensus Estimate | -0.23 | -0.15 | -0.98 | -1.38 |
Earnings ESP | 0.00% | 0.00% | 4.08% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.27 | -0.22 | -0.16 | -0.21 | NA |
Estimate | -0.38 | -0.31 | -0.25 | -0.17 | NA |
Difference | 0.11 | 0.09 | 0.09 | -0.04 | 0.06 |
Surprise | 28.95% | 29.03% | 36.00% | -23.53% | 17.61% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more